Scott Grindrod

577 total citations
21 papers, 492 citations indexed

About

Scott Grindrod is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Scott Grindrod has authored 21 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Scott Grindrod's work include Histone Deacetylase Inhibitors Research (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Peptidase Inhibition and Analysis (3 papers). Scott Grindrod is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Peptidase Inhibition and Analysis (3 papers). Scott Grindrod collaborates with scholars based in United States and Spain. Scott Grindrod's co-authors include Milton L. Brown, Mikell Paige, Sivanesan Dakshanamurthy, Gary M. Chinigo, M. Chruszcz, W. Minor, Ernest Hamel, G. Richard Geier, Yali Kong and Anatoly Dritschilo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemistry.

In The Last Decade

Scott Grindrod

19 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Grindrod United States 12 276 193 68 50 34 21 492
Homayon J. Arabshahi New Zealand 11 254 0.9× 221 1.1× 155 2.3× 23 0.5× 28 0.8× 17 499
Gwénaël Chevé France 12 147 0.5× 262 1.4× 82 1.2× 61 1.2× 69 2.0× 20 547
José A. Gómez-Vidal Spain 16 277 1.0× 301 1.6× 66 1.0× 21 0.4× 33 1.0× 30 623
Jiuling Li China 15 296 1.1× 123 0.6× 44 0.6× 31 0.6× 65 1.9× 40 500
Nicholas J. Newcombe United Kingdom 16 500 1.8× 304 1.6× 88 1.3× 47 0.9× 33 1.0× 25 751
Fengrong Xu China 15 176 0.6× 203 1.1× 78 1.1× 53 1.1× 26 0.8× 32 456
John B. Feltenberger United States 15 408 1.5× 225 1.2× 54 0.8× 15 0.3× 41 1.2× 23 764
Steven C. Zammit Australia 13 291 1.1× 153 0.8× 42 0.6× 25 0.5× 16 0.5× 14 481
Yong‐Cheng Ma China 13 344 1.2× 275 1.4× 53 0.8× 42 0.8× 20 0.6× 19 630
Michaël Prakesch Canada 15 324 1.2× 287 1.5× 64 0.9× 18 0.4× 56 1.6× 25 609

Countries citing papers authored by Scott Grindrod

Since Specialization
Citations

This map shows the geographic impact of Scott Grindrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Grindrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Grindrod more than expected).

Fields of papers citing papers by Scott Grindrod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Grindrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Grindrod. The network helps show where Scott Grindrod may publish in the future.

Co-authorship network of co-authors of Scott Grindrod

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Grindrod. A scholar is included among the top collaborators of Scott Grindrod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Grindrod. Scott Grindrod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Mira, Nicole S. Nicholas, Scott Grindrod, & Anatoly Dritschilo. (2024). Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth. PLoS ONE. 19(7). e0306168–e0306168. 3 indexed citations
2.
Grindrod, Scott, et al.. (2024). Abstract A005: Enhanced DNA damage and disruption of repair by iodinated thymidine analogues with Tipiracil for clinical radiation sensitization. Cancer Research. 84(1_Supplement). A005–A005. 1 indexed citations
3.
Noonepalle, Satish, Scott Grindrod, Nima Aghdam, et al.. (2023). Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition. Molecular Cancer Therapeutics. 22(12). 1376–1389. 11 indexed citations
4.
Jung, Mira, Keith Kowalczyk, Gaurav Bandi, et al.. (2022). Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients. Cancer Research Communications. 2(12). 1617–1625. 4 indexed citations
5.
Cheema, Amrita K., Yaoxiang Li, Keith Kowalczyk, et al.. (2022). Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers. Clinical Cancer Research. 29(5). 921–929. 8 indexed citations
6.
Cheema, Amrita K., Scott Grindrod, Xiaogang Zhong, et al.. (2019). Discovery of Metabolic Biomarkers Predicting Radiation Therapy Late Effects in Prostate Cancer Patients. Advances in experimental medicine and biology. 1164. 141–150. 6 indexed citations
7.
Woodrick, Jordan, Scott Grindrod, Li Zhang, et al.. (2016). Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery. Bioconjugate Chemistry. 27(9). 1981–1990. 5 indexed citations
8.
Ma, Yongxian, York Tomita, Anju Preet, et al.. (2014). Small-Molecule “BRCA1-Mimetics” Are Antagonists of Estrogen Receptor-α. Molecular Endocrinology. 28(12). 1971–1986. 5 indexed citations
9.
Hou, Shujie, Yong Weon Yi, Hyo Jin Kang, et al.. (2014). Novel Carbazole Inhibits Phospho-STAT3 through Induction of Protein–Tyrosine Phosphatase PTPN6. Journal of Medicinal Chemistry. 57(15). 6342–6353. 43 indexed citations
10.
Grindrod, Scott, Li Zhang, Sivanesan Dakshanamurthy, et al.. (2012). Synthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent. Bioorganic & Medicinal Chemistry. 20(17). 5269–5276. 11 indexed citations
11.
Kong, Yali, Mira Jung, Kan Wang, et al.. (2011). Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor. Molecular Cancer Therapeutics. 10(9). 1591–1599. 39 indexed citations
12.
Yenugonda, Venkata Mahidhar, Tushar B. Deb, Scott Grindrod, et al.. (2011). Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells. Bioorganic & Medicinal Chemistry. 19(8). 2714–2725. 18 indexed citations
13.
Grindrod, Scott. (2011). Effects of a fluorescent myosin light chain phosphatase inhibitor on prostate cancer cells. SHILAP Revista de lepidopterología. 1. 27–27. 14 indexed citations
14.
Ringer, Lymor, Paul Sirajuddin, Venkata Mahidhar Yenugonda, et al.. (2010). VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells. Cancer Biology & Therapy. 10(4). 320–325. 11 indexed citations
15.
Hans, S., Fatoumata Camara, Alejandro Martín‐Montalvo, et al.. (2010). Synthesis of C-glycoside analogues of β-galactosamine-(1→4)-3-O-methyl-d-chiro-inositol and assay as activator of protein phosphatases PDHP and PP2Cα. Bioorganic & Medicinal Chemistry. 18(3). 1103–1110. 15 indexed citations
16.
Banerjee, Partha P., Shankar Jagadeesh, Scott Grindrod, et al.. (2010). Fluorescent Epigenetic Small Molecule Induces Expression of the Tumor Suppressor Ras-Association Domain Family 1A and Inhibits Human Prostate Xenograft. Journal of Medicinal Chemistry. 53(6). 2376–2382. 27 indexed citations
17.
Chinigo, Gary M., Mikell Paige, Scott Grindrod, et al.. (2008). Asymmetric Synthesis of 2,3-Dihydro-2-arylquinazolin-4-ones: Methodology and Application to a Potent Fluorescent Tubulin Inhibitor with Anticancer Activity. Journal of Medicinal Chemistry. 51(15). 4620–4631. 190 indexed citations
18.
Brautigan, David L., Milton L. Brown, Scott Grindrod, et al.. (2005). Allosteric Activation of Protein Phosphatase 2C by d-chiro-Inositol−Galactosamine, a Putative Mediator Mimetic of Insulin Action. Biochemistry. 44(33). 11067–11073. 43 indexed citations
19.
20.
Geier, G. Richard & Scott Grindrod. (2004). Meso-Substituted [34]Octaphyrin(1.1.1.0.1.1.1.0) and Corrole Formation in Reactions of a Dipyrromethanedicarbinol with 2,2‘-Bipyrrole. The Journal of Organic Chemistry. 69(19). 6404–6412. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Homayon J. Arabshahi Breakdown of academic impact, for papers by Gwénaël Chevé Breakdown of academic impact, for papers by José A. Gómez-Vidal Breakdown of academic impact, for papers by Jiuling Li Breakdown of academic impact, for papers by Nicholas J. Newcombe Breakdown of academic impact, for papers by Fengrong Xu Breakdown of academic impact, for papers by John B. Feltenberger Breakdown of academic impact, for papers by Steven C. Zammit Breakdown of academic impact, for papers by Yong‐Cheng Ma Breakdown of academic impact, for papers by Michaël Prakesch
Rankless by CCL
2026